Alrifai, D;
(2017)
Evaluation of CA 19-9, a predictive biomarker of response and survival in patients undergoing chemotherapy for metastatic pancreatic ductal adenocarcinoma.
Presented at: ESMO World Congress on Gastrointestinal Cancer 2018, Barcelona, Spain.
Preview |
Text
Alrifai_GI ESMO abstract 24.04.17 for re-submission.pdf - Accepted Version Download (253kB) | Preview |
| Type: | Conference item (Presentation) |
|---|---|
| Title: | Evaluation of CA 19-9, a predictive biomarker of response and survival in patients undergoing chemotherapy for metastatic pancreatic ductal adenocarcinoma |
| Event: | ESMO World Congress on Gastrointestinal Cancer 2018 |
| Location: | Barcelona, Spain |
| Dates: | 20-23 June 2018 |
| Open access status: | An open access version is available from UCL Discovery |
| Publisher version: | https://www.esmo.org/Conferences/Past-Conferences/... |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10057952 |
Downloads since deposit
36Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months
Archive Staff Only
 |
View Item |
